BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37404563)

  • 21. LAMA2-Related Dystrophies: Clinical Phenotypes, Disease Biomarkers, and Clinical Trial Readiness.
    Sarkozy A; Foley AR; Zambon AA; Bönnemann CG; Muntoni F
    Front Mol Neurosci; 2020; 13():123. PubMed ID: 32848593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Merosin-deficient congenital muscular dystrophy type 1A: A case report.
    He Z; Luo X; Liang L; Li P; Li D; Zhe M
    Exp Ther Med; 2013 Nov; 6(5):1233-1236. PubMed ID: 24223650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cryptic intronic LAMA2 insertion in a boy with mild congenital muscular dystrophy type 1A.
    Specht S; Duff J; Charlton R; Polvikoski T; Barresi R; Töpf A; Straub V
    Neuromuscul Disord; 2021 Jul; 31(7):660-665. PubMed ID: 34074572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compound heterozygous
    Zhang C; Zheng X; Lu D; Xu L; Che F; Liu S
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33899113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limb girdle muscular dystrophy due to LAMA2 mutations: diagnostic difficulties due to associated peripheral neuropathy.
    Chan SH; Foley AR; Phadke R; Mathew AA; Pitt M; Sewry C; Muntoni F
    Neuromuscul Disord; 2014 Aug; 24(8):677-83. PubMed ID: 24957499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exome sequencing detects compound heterozygous nonsense LAMA2 mutations in two siblings with atypical phenotype and nearly normal brain MRI.
    Saredi S; Gibertini S; Matalonga L; Farina L; Ardissone A; Moroni I; Mora M
    Neuromuscul Disord; 2019 May; 29(5):376-380. PubMed ID: 31040037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Merosin-deficient congenital muscular dystrophy type 1A.
    Buteică E; Roşulescu E; Burada F; Stănoiu B; Zăvăleanu M
    Rom J Morphol Embryol; 2008; 49(2):229-33. PubMed ID: 18516331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LAMA2 Congenital Muscle Dystrophy: A Novel Pathogenic Mutation in Bulgarian Patient.
    Dimova I; Kremensky I
    Case Rep Genet; 2018; 2018():3028145. PubMed ID: 30147969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rare variant in
    Amin M; Bakhit Y; Koko M; Ibrahim MOM; Salih MA; Ibrahim M; Seidi OA
    Acta Myol; 2019 Mar; 38(1):21-24. PubMed ID: 31309178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy.
    Nguyen Q; Lim KRQ; Yokota T
    Appl Clin Genet; 2019; 12():113-130. PubMed ID: 31308722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laminin alpha 2-chain gene mutations in two siblings presenting with limb-girdle muscular dystrophy.
    Naom I; D'Alessandro M; Sewry CA; Philpot J; Manzur AY; Dubowitz V; Muntoni F
    Neuromuscul Disord; 1998 Oct; 8(7):495-501. PubMed ID: 9829280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel compound heterozygous mutations in the TTN gene: elongation and truncation variants causing limb-girdle muscular dystrophy type 2J in a Han Chinese family.
    Wang G; Lv X; Xu L; Zhang R; Yan C; Lin P
    Neurol Sci; 2022 May; 43(5):3427-3433. PubMed ID: 35239051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Mosaic Mutation in the
    Chausova PA; Ryzhkova OP; Rudenskaya GE; Chernykh VB; Shchagina OA; Polyakov AV
    Front Genet; 2021; 12():686800. PubMed ID: 34777456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscle MRI findings in a one-year-old girl with merosin-deficient congenital muscular dystrophy type 1A due to LAMA2 mutation: A case report.
    Liang Y; Li G; Chen S; He R; Zhou X; Chen Y; Xu X; Zhu R; Zhang C
    Biomed Rep; 2017 Aug; 7(2):193-196. PubMed ID: 28804634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exome sequencing identifies a DNAJB6 mutation in a family with dominantly-inherited limb-girdle muscular dystrophy.
    Couthouis J; Raphael AR; Siskind C; Findlay AR; Buenrostro JD; Greenleaf WJ; Vogel H; Day JW; Flanigan KM; Gitler AD
    Neuromuscul Disord; 2014 May; 24(5):431-5. PubMed ID: 24594375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased polyamines as protective disease modifiers in congenital muscular dystrophy.
    Kemaladewi DU; Benjamin JS; Hyatt E; Ivakine EA; Cohn RD
    Hum Mol Genet; 2018 Jun; 27(11):1905-1912. PubMed ID: 29566247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and functional characterization of a novel heterozygous splice‑site mutation in the calpain 3 gene causes rare autosomal dominant limb‑girdle muscular dystrophy.
    Mao B; Yang J; Zhao X; Jia X; Shi X; Zhao L; Banerjee S; Zhang L; Ma X
    Exp Ther Med; 2024 Mar; 27(3):97. PubMed ID: 38356676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital Muscular Dystrophy Due to Merosin Deficiency: Report of a New Mutation.
    Herrera Malpica WS; Ortiz-Corredor F; Sanchez Peñarete D; Muñetones Hernández PV
    Cureus; 2023 Jun; 15(6):e39988. PubMed ID: 37416022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical features and LAMA2 mutations of patients with congenital muscular dystrophy type 1A: a case report and literature review].
    Guo L; Tang WM; Song YZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jun; 22(6):608-613. PubMed ID: 32571460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zebrafish Models of
    Fabian L; Dowling JJ
    Front Mol Neurosci; 2020; 13():122. PubMed ID: 32742259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.